Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients

Summary

New England Journal of Medicine publishes ahead-of-print research on clopidogrel versus dual antiplatelet therapy in high-ischemic-risk patients. The article title and source are provided with no additional clinical outcome data or context available.